Research Article
One-Year Clinical Outcome in Middle Eastern Patients with Atrial Fibrillation: The Jordan Atrial Fibrillation (JoFib) Study
Table 4
Multivariate analysis of factors associated with all-cause death and stroke/SE among patients with nonvalvular atrial fibrillation.
| | Variable | Odds ratio | 95% confidence interval | value |
| | All-cause death | | | | | Type 2 diabetes | 1.5 | 1.1-2.1 | 0.01 | | Age>75 years | 2.4 | 1.6-3.5 | <0.001 | | Enrolled as in-patient | 4.1 | 3.0-5.6 | <0.001 | | BMI<25 kg/m2 | 0.7 | 0.5-0.9 | 0.02 | | CHD | 1.7 | 1.1-2.5 | 0.02 | | Heart failure | 2.4 | 1.7-3.3 | <0.0001 | | Use of OACs | 0.4 | 0.3-0.6 | <0.0001 | | Major bleeding | 2.3 | 1.2-4.4 | 0.02 | | Stroke/SE | | | | | Hypertension | 1.9 | 1.0-3.8 | 0.05 | | Enrolled as in-patient | 3.1 | 2.1-4.7 | <0.001 | | CKD | 1.8 | 1.1-3.1 | 0.02 | | High-risk CHA2DS2-VASc score | 5.8 | 1.4-24.4 | 0.02 | | Prior history of stroke | 3.4 | 2.3-5.2 | <0.0001 |
|
|
BMI: body mass index; CHD: coronary heart disease; CKD: chronic kidney disease; OAC: oral anticoagulants; SE: systemic embolism.
|
